Quartzy
+65%
est. 2Y upside i
Marketplace for life science supplies.
Rank
#814
Sector
Life Sciences Software
Est. Liquidity
~4Y
Data Quality
Data: MediumQuartzy offers a moderate risk/reward for a job candidate.
Last updated: July 21, 2026
Revenue grows modestly to $15.5M, but exit multiple expands to 8x on IPO window or category leadership, implying a $124M exit — a 2.9x return on the $42.3M entry valuation.
Revenue grows to $15.5M, multiple converges to 6x in line with comps, implying ~$93M exit, a 2.2x return.
Revenue growth disappoints, multiple compresses to 2.5x, implying ~$39M exit, below $76M of preferred stock — common stock recovers -100%.
Preference Stack Risk
severeFunding Intensity
17970%Total funding of $76M exceeds entry valuation of $42.3M, meaning common stock is deep underwater in any exit below ~$76M.
Dilution Risk
lowRecent debt financing suggests no near-term equity raise; dilution risk is minimal.
Secondary Liquidity
noneNo secondary market data available; common stock likely illiquid until a liquidity event.
Marketing — 2 roles
- Life Science Field Marketing Associate · Hayward, California
- Product Marketing Manager · Remote
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Quartzy's data — designed to show you've done your homework.
- 1
“How would you evaluate the threat from larger incumbents like SAP Ariba or Thermo Fisher entering your niche?”
- 2
“With only 5% market penetration in a $21B SAM, what is your go-to-market strategy to accelerate growth?”
- 3
“Given the preference stack of $76M on a $42M valuation, how do you think about common stock value in a sale scenario?”
Community
Valuation Sentiment
Our model estimates +65% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.